CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Palpation Diagnostics is developing ProstaPalp, a medical device that measures prostate characteristics during examinations. This technology aims to reduce unnecessary biopsies for prostate cancer, providing a less invasive triage option for patient monitoring.
Palpation Diagnostics is developing the ProstaPalp technology, a novel in vivo medical device, which can measure the physical characteristics of the prostate during a routine digital rectal examination.
The technology has been developed over the last 17 years in collaboration between clinicians at the Edinburgh Western General Hospital and engineers at Heriot-Watt University.The technology addresses the unmet need of a diagnostic that can be used in the active monitoring and triaging of patients…
PALPATION DIAGNOSTICS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
